Norman, Robert J.

Treatment of obesity in polycystic ovary syndrome: A position statement of the Androgen Excess and Polycystic Ovary Syndrome Society

Moran, L. J., Pasquali, R., Teede, H. J., Hoeger, K. M., & Norman, R. J. (2009) · Fertility and Sterility

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 444

Ethnicity, Obesity and the Prevalence of Impaired Glucose Tolerance and Type 2 Diabetes in PCOS: A Systematic Review and Meta-Regression

Kakoly, N. S., Khomami, M. B., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., Ranasinha, S., Teede, H. J., & Moran, L. J. (2018) · Human Reproduction Update

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 384

Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline

Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia

Ovarian function and disordersGenetic and Kidney Cyst Diseases

Cited by 379

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome

Norman, R. J., Masters, L., Milner, C. R., Wang, J. X., & Davies, M. J. (2001) · Human Reproduction

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 341

The role of lifestyle modification in polycystic ovary syndrome

Norman, R. J., Davies, M. J., Lord, J., & Moran, L. J. (2002) · Trends in Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 326

Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta‐analysis and meta‐regression

Lim, S. S., Kakoly, N. S., Tan, J. W. J., Fitzgerald, G., Bahri Khomami, M., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., et al. (2019) · Obesity Reviews

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 316

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

Morley, L. C., Tang, T., Yasmin, E., Norman, R. J., & Balen, A. H. (2017) · Cochrane Database of Systematic Reviews

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 296

Lifestyle changes in women with polycystic ovary syndrome

Moran, L. J., Hutchison, S. K., Norman, R. J., & Teede, H. J. (2011) · Cochrane Database of Systematic Reviews

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 292

The Effect of a Hypocaloric Diet with and without Exercise Training on Body Composition, Cardiometabolic Risk Profile, and Reproductive Function in Overweight and Obese Women with Polycystic Ovary Syndrome

Thomson, R. L., Buckley, J. D., Noakes, M., Clifton, P. M., Norman, R. J., & Brinkworth, G. D. (2008) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 277

Metabolic risk in PCOS: Phenotype and adiposity impact

Moran, L. J., Norman, R. J., & Teede, H. J. (2015) · Trends in Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 245

Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome

Thomson, R. L., Buckley, J. D., Lim, S. S., Noakes, M., Clifton, P. M., Norman, R. J., & Brinkworth, G. D. (2010) · Fertility and Sterility

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 207

Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia

Boyle, J. A., Cunningham, J., OˈDea, K., Dunbar, T., & Norman, R. J. (2012) · Medical Journal of Australia

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 160

Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome

Moran, L. J., Noakes, M., Clifton, P. M., Wittert, G. A., Williams, G., & Norman, R. J. (2006) · The American Journal of Clinical Nutrition

Ovarian function and disordersDiet and metabolism studies

Cited by 141

Erratum. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & International PCOS Network (2019) · Human Reproduction

Ovarian function and disordersGenetic and Kidney Cyst Diseases

Cited by 120

Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management

Cussons, A. J., Stuckey, B. G. A., Walsh, J. P., Burke, V., & Norman, R. J. (2005) · Clinical Endocrinology

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 119

Translation and implementation of the Australian‐led PCOS guideline: clinical summary and translation resources from the International Evidence‐based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Teede, H. J., Misso, M. L., Boyle, J. A., Garad, R. M., McAllister, V., Downes, L., Gibson‐Helm, M., Hart, R. J., Rombauts, L., Moran, L., et al. (2018) · Medical Journal of Australia

Ovarian function and disordersClinical practice guidelines implementation

Cited by 115

Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis

Nieuwenhuis-Ruifrok, A. E., Kuchenbecker, W. K. H., Hoek, A., Middleton, P., & Norman, R. J. (2008) · Human Reproduction Update

Ovarian function and disordersPharmacology and Obesity Treatment

Cited by 110

Psychological benefits of a high-protein, low-carbohydrate diet in obese women with polycystic ovary syndrome—A pilot study

Galletly, C., Moran, L., Noakes, M., Clifton, P., Tomlinson, L., & Norman, R. (2007) · Appetite

Ovarian function and disordersEating Disorders and Behaviors

Cited by 103

Polycystic ovary syndrome: perceptions and attitudes of women and primary health care physicians on features of PCOS and renaming the syndrome

Teede, H., Gibson-Helm, M., Norman, R. J., & Boyle, J. (2014) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 93

Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome

Norman, R. J., Milner, C. R., Groome, N. P., & Robertson, D. M. (2001) · Human Reproduction

Ovarian function and disordersReproductive Biology and Fertility

Cited by 91

Preconception lifestyle advice for people with subfertility

Anderson, K., Norman, R. J., & Middleton, P. (2010) · Cochrane Database of Systematic Reviews

Reproductive Health and TechnologiesReproductive Health and Contraception

Cited by 85

Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis

Misso, M. L., Costello, M. F., Garrubba, M., Wong, J., Hart, R., Rombauts, L., Melder, A. M., Norman, R. J., & Teede, H. J. (2013) · Human Reproduction Update

Ovarian function and disordersReproductive Health and Technologies

Cited by 81

Top 10 priorities for future infertility research: an international consensus development study

Duffy, J. M. N., Adamson, G. D., Benson, E., Bhattacharya, S., Bhattacharya, S., Bofill, M., Brian, K., Collura, B., Curtis, C., Evers, J. L. H., et al. (2021) · Fertility and Sterility

Reproductive Health and TechnologiesDelphi Technique in Research

Cited by 75

C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome

Moran, L. J., Noakes, M., Clifton, P. M., Wittert, G. A., Belobrajdic, D. P., & Norman, R. J. (2007) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 66